Myomo (MYO)
(Delayed Data from AMEX)
$2.87 USD
+0.05 (1.77%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $2.84 -0.03 (-1.05%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Myomo, Inc. (MYO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.50 | $7.00 | $6.00 | 131.32% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Myomo, Inc. comes to $6.50. The forecasts range from a low of $6.00 to a high of $7.00. The average price target represents an increase of 131.32% from the last closing price of $2.81.
Analyst Price Targets (3 )
Broker Rating
Myomo, Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/MYO.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/20/2024 | Lake Street Capital Markets | Benjamin Haynor | Not Available | Strong Buy |
4/2/2024 | H.C. Wainwright & Co. | Sean Lee | Strong Buy | Strong Buy |
3/15/2024 | Maxim Group | Anthony V Vendetti | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 3 |
Average Target Price | $6.50 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 157 of 252 |
Current Quarter EPS Est: | -0.07 |